Table 2.
Medical therapy at discharge
| Poor (n=147) | Moderate (n=632) | Good (n=207) | P value | |
| ACEI or ARB | 30 (20.4) | 535 (84.7) | 207 (100) | <0.001 |
| ACEI | 12 (8.2) | 247 (39.1) | 99 (47.8) | <0.001 |
| Ramipril equivalent dose (mg) | 2.3±1.4 | 2.6±1.8 | 3.0±2.2 | 0.29 |
| ARB | 18 (12.2) | 251 (39.7) | 99 (47.8) | <0.001 |
| Candesartan equivalent dose (mg) | 10.2±7.5 | 9.8±6.7 | 9.9±6.4 | 0.75 |
| β-Blocker | 24 (16.3) | 355 (56.2) | 207 (100) | <0.001 |
| Carvedilol equivalent dose (mg) | 12.5±11.4 | 19.3±20.7 | 16.2±16.8 | 0.08 |
| MRA | 129 (12.2) | 367 (58.1) | 207 (100) | <0.001 |
| MRA dose at discharge (mg) | 24.0±13.2 | 24.0±13.8 | 23.4±14.0 | 0.90 |
| Warfarin | 38 (25.9) | 362 (57.3) | 207 (100) | <0.001 |
| Loop diuretics | 97 (66.0) | 493 (78.0) | 180 (87.0) | <0.001 |
| Thiazide diuretics | 10 (6.8) | 38 (6.0) | 16 (7.7) | 0.21 |
| Amiodarone | 21 (14.3) | 84 (13.3) | 19 (9.2) | 0.26 |
| Digitalis | 48 (32.7) | 347 (54.9) | 127 (61.4) | <0.001 |
Values are presented as numbers (%) or mean±SD, unless otherwise indicated.
ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonists.